SOBR SAFE INC (SOBR)

US8335922071 - Common Stock

0.253  -0.01 (-2.84%)

After market: 0.26 +0.01 (+2.77%)

Fundamental Rating

1

SOBR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 127 industry peers in the Electronic Equipment, Instruments & Components industry. SOBR may be in some trouble as it scores bad on both profitability and health. SOBR has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year SOBR has reported negative net income.
SOBR had a negative operating cash flow in the past year.
SOBR had negative earnings in each of the past 5 years.
SOBR had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -166.12%, SOBR is not doing good in the industry: 94.44% of the companies in the same industry are doing better.
SOBR has a worse Return On Equity (-501.50%) than 94.44% of its industry peers.
Industry RankSector Rank
ROA -166.12%
ROE -501.5%
ROIC N/A
ROA(3y)-176.08%
ROA(5y)-292.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SOBR's Gross Margin of 40.74% is fine compared to the rest of the industry. SOBR outperforms 74.60% of its industry peers.
SOBR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

SOBR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SOBR has more shares outstanding
The number of shares outstanding for SOBR has been increased compared to 5 years ago.
The debt/assets ratio for SOBR is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -24.00, we must say that SOBR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -24.00, SOBR is doing worse than 92.06% of the companies in the same industry.
A Debt/Equity ratio of 1.13 is on the high side and indicates that SOBR has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.13, SOBR is doing worse than 88.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF N/A
Altman-Z -24
ROIC/WACCN/A
WACC12.45%

2.3 Liquidity

A Current Ratio of 2.21 indicates that SOBR has no problem at all paying its short term obligations.
SOBR has a Current ratio (2.21) which is in line with its industry peers.
SOBR has a Quick Ratio of 1.98. This is a normal value and indicates that SOBR is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.98, SOBR perfoms like the industry average, outperforming 58.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.98

1

3. Growth

3.1 Past

SOBR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 71.08%, which is quite impressive.
SOBR shows a strong growth in Revenue. In the last year, the Revenue has grown by 451.83%.
EPS 1Y (TTM)71.08%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q40.51%
Revenue 1Y (TTM)451.83%
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2Q77.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y31.25%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year100%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

SOBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SOBR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SOBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SOBR SAFE INC

NASDAQ:SOBR (4/22/2024, 7:00:03 PM)

After market: 0.26 +0.01 (+2.77%)

0.253

-0.01 (-2.84%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.06M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -166.12%
ROE -501.5%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 40.74%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.21
Quick Ratio 1.98
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)71.08%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y31.25%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)451.83%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y